Navigation Links
Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
Date:10/11/2011

LOS ANGELES, Oct. 11, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced it has entered into a Patent License Agreement (the "License Agreement") with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services ("NIH").  Pursuant to the License Agreement, NIH granted to the Company a non-exclusive worldwide license to 43 patents and patent applications, consisting of 9 issued United States patents, 13 United States patent applications, and 21 foreign corresponding patents and patent applications relating to adoptive cell therapy using autologous tumor infiltrating lymphocytes (TILs) for the treatment of certain cancers.  The Company also has rights to sublicense the intellectual property subject to the terms and conditions set forth in the License Agreement.  The License Agreement will expire on a product-by-product basis upon the expiration of the subject patent rights.  

These technologies were also the subject of the Cooperative Research and Development Agreement, effective August 5, 2011, as disclosed previously in the Company's Current Report on Form 8-K filed on August 11, 2011.  

In consideration for the License Agreement, the Company agreed to pay approximately $1.2 million in upfront licensing fees and expense reimbursements within 60 days of the effectiveness of the License Agreement, royalties based on a percentage of net sales (subject to certain annual minimum royalty payments), and a percentage of revenues from any sublicensing arrangements.  In addition, the Company will make additional payments on the achievement of certain clinical and regulatory milestones for each of the various indications.  

"We are very pleased to finalize this License Agreement as it will now allow us to move forward with the clinical developmen
'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
2. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
3. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
4. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
5. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
6. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
7. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
8. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
9. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
10. ThermoGenesis Announces National Institute of Health Grant
11. Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MILFORD, Mass. , Sept. 18, 2014 /PRNewswire/ ... developing novel therapeutics for the treatment of RNA ... National Institutes of Health (NIH) for animal testing ... multiple viral pathogens, classified as "Special Pathogens," against ... SB 9200, derived from Spring Bank,s ...
(Date:9/18/2014)... /CNW/ - A new expert panel report, Improving Medicines ... released today by the Council of Canadian Academies, addresses ... children. Each year about half of Canada,s ... prescription drug. Much of this prescribing is done off-label ... potential health risks. Children have historically been ...
(Date:9/18/2014)... Pa. , Sept. 18, 2014   ... ), a specialty biopharmaceutical company, today announced the ... from the AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of ... study. This study evaluated collagenase clostridium histolyticum (CCH) ... in the same hand. In addition, the study ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... (Nasdaq: CHBT ) ("China-Biotics" or "the Company"), a leading ... its unaudited financial results for the third quarter and nine months ... Third Quarter FY2011 Highlights ... $32.4 million; Bulk products sales increased 14 ...
... NEW YORK, Feb. 9, 2011 Reportlinker.com announces that ... catalogue: Analytical Tool - Cancer Therapeutic ... "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique ... that have emerged in antibody drug development for the ...
Cached Medicine Technology:China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 2China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 3China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 4China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 5China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 6China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 7China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 8China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 9China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 10China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 11Reportlinker Adds Analytical Tool - Cancer Therapeutic Antibodies 2Reportlinker Adds Analytical Tool - Cancer Therapeutic Antibodies 3
(Date:9/19/2014)... with friends is a big part of being young, and ... look graceful without spending a large sum of money. Recently, ... prom dresses. Apart from this, it has launched a big ... all the global consumers can enjoy a discount, up to ... , The company’s chief executive officer says, “We are proud ...
(Date:9/18/2014)... Petersburg, FL (PRWEB) September 19, 2014 ... with patented ingredients made just for these issues in ... includes Matrixyl, Haloxyl and Eyeliss," says Kathy Heshelow, founder ... inflammation, improving circulation and boosting collagen, to improve the ... special eye serum for wrinkles, dark circles and ...
(Date:9/18/2014)... September 18, 2014 Active Aging Week ... older as fully participating members of society and promotes ... celebrate, The Stafford – a boutique retirement community located ... will host two screenings of Cyber-Seniors - a humorous ... our residents to watch this great film,” says Thomas ...
(Date:9/18/2014)... Dr. David A. F. Ellis is a ... of Facial Plastic and Reconstructive Surgery and a Professor ... Facial Plastic Surgery. He is recognized around the ... , Dr. Ellis will be presenting on numerous injectable ... injection techniques and various treatments for complications associated with ...
(Date:9/18/2014)... 2014 A jacket is a hip- ... typically has sleeves, and fastens in the front or ... tighter-fitting, and less insulating than a coat, which is ... protective clothing. Today, Fecbek, a well-known clothing manufacturer and ... men’s jackets; all these items are offered at extremely ...
Breaking Medicine News(10 mins):Health News:With New Semester Under Way, LunaDress Unveils The Most Fashionable Prom Dresses 2Health News:The Secret to Improving Under-Eye Skin: 30% Off Sale and Report on Ingredients Ends Tonight on the Face Whisperer® Advanced Eye Gel 2Health News:In Support of Active Aging Week, a Lake Oswego Retirement Community Will Get a Sneak Peek at an Inter-Generational Documentary – Cyber-Seniors 2Health News:Dr. David A. F. Ellis Has Been Invited to Speak at a Conference of the American Academy of Facial Plastic and Reconstructive Surgery in Orlando, Florida 2Health News:Cool Jackets Are For Sale At Fecbek.com 2
... largest meat processor, Maple Leaf Foods, on Tuesday decided to ... of its meat // products with an unknown contaminant. ... when Maple Leaf Employees found syringe casings at the company's ... Federal agency and CFIA's food safety officer, Garfield Balsom took ...
... World Ayurveda Congress at the University of Pune on ... Anbumani Ramadoss, //announced a series of steps to be ... India and abroad. He said, 'In a scenario where ... India’s rich tradition needed to be tapped and packaged ...
... wonder then, that the University of Queensland, Queensland ... David Fleay's Wildlife Park and the Zoological Society ... interesting project. The combined project is an artificial ... Monday and scientists believe the technique can be ...
... filed an appeal with the Pakistan Cricket Board (PCB) to ... tribunal on Nov 1.// ,Shoaib handed over the ... newspaper Wednesday quoted the PCB spokesperson as saying. ,Another ... ban by the same doping tribunal, filed his appeal to ...
... study that by actually allowing a stream of mild electrical ... stimulate a person’s mind helping him definitely to clearly recall ... ordinarily be able to do. ,Neuroscientist Lisa Marshall of ... found that applying electrical stimuli to the brain scalp which ...
... hearted - there is a 1 in 300 chance of dying ... England Sir Liam Donaldson has said in a cautionary message . ... WHO's campaign on the need for hospitals to address hygiene issues ... the chances of dying in an aircrash hollow , where the ...
Cached Medicine News:Health News:Government Announces Steps To Promote Ayurvedic Medicine 2
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... Antigen-Antibody Pens-Using a proprietary and patented technology, ... pens, called Antigen-Antibody pens-TM, that will allow ... membranes in any form or shape or ... helps to see antigen being written on ...
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... 350 Liters of pure water, Complete, Compact ... Purified Water,Millipores compact S.D.S. Storage and Distribution ... 350 liters of purified water produced by ... consistent purity of stored water, provide effective ...
Medicine Products: